Sutacimig is an investigational bispecific antibody designed to bind to endogenous factor VIIa and localize it to activated platelets, thereby promoting thrombin and fibrin formation.
Hemab Therapeutics, a late stage clinical biotechnology company developing novel prophylactic therapeutics for serious, underserved coagulation disorders, today announced that the U.S. Food and Drug ...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, today announced the first patient ...
DAME Deborah James’ science laboratory will be part of a project awarded £20million by Cancer Research UK to test a new way ...
Not having her pain taken seriously even led her to question herself, until, finally, she got a diagnosis of endometriosis 17 ...
Some Samsung Galaxy S26 Ultra users say the Privacy Display compromises the overall display experience.
Dr. Bharat Agravat is a world-renowned Dental Implant Surgeon, Innovator, and Mentor with 28 years of clinical expertise. As India's first dentist trained at Harvard University, NYU, and the ...
The Detroit Pistons got a tough three-game road trip started on the right foot Sunday night as they dispatched the Orlando ...
It’s a Monday morning in Malibu and Claire Rosinkranz has just cut her bangs. The new fringe suits her well, with the curtain ...
Stop hiring armies of full-time staff for every AI trend; use specialized "bolt-on" teams to build your tech, then scale back ...
To highlight where the vaccine could have the biggest impact, Condoms.UK analysed NHS data to uncover England ’s top ...
In our increasingly divided world, the American photographers portraits of subcultures, from surfers to LA’s ‘leather dyke’ ...